Chapter 9 : Surgical Pharmacology and Anesthesia
Across
- 2. Induction of a reversible loss of consciousness and sensation throughout the entire body.
- 6. Overall period when the effects of a medication are demonstrated.
- 8. Use of pharmaceutical agents to disrupt sensory nerve impulses.
- 9. A container for multiple doses of medication, typically sealed with a rubber stopper.
- 11. Responsible for approving drugs for safety, dosage accuracy, and effectiveness.
- 13. Concentration or dose of medication producing the desired result without harmful effects.
- 16. A sealed glass container for single-dose medications.
- 17. Lowest abuse potential, limited quantities of certain narcotic drugs for medical use - cough syrups with codeine, diphenoxylate (Lomotil), etc.
- 18. Example for Warfarin is Vitamin K.
- 22. Amount of medication delivered to achieve the optimal therapeutic effect.
- 23. Expected undesirable effects of a medication.
- 26. Examples: Lidocaine, Propofol.
- 29. 4 Phases:Induction, maintenance, emergence, and recovery.
- 32. Include gas, liquid (solution, suspension), solid (powder, capsule, tablet), and semisolid (cream, ointment) forms.
- 34. Medical conditions that the medication treats.
- 36. Injection of an anesthetic agent into the cerebrospinal fluid within the subarachnoid space.
- 40. Used in diagnostic radiographic procedures. Examples: Hypaque, Cystografin.
- 41. Time required for the effects of a medication to begin.
- 42. Local anesthetic is injected to interrupt the transmission of nerve signals.
- 44. A container for topical medications such as ointments and creams.
- 45. Reduction in the effect of a medication over time.
- 46. Right patient, drug, dose, route, time, and documentation.
- 47. Classification of drugs based on their potential for abuse and therapeutic indication.
- 48. Trade/brand, generic, and chemical names.
Down
- 1. Circumstances or medical conditions where the medication should not be used.
- 3. Also known as Sellick's maneuver, it's a technique used to compress the cartilage to reduce the risk of aspiration during induction of anesthesia.
- 4. Example: Heparin.
- 5. Time of maximum effect(s) of the medication.
- 7. A syringe prefilled with a specific dose of medication for immediate use.
- 10. Injects the agent directly into tissues around a peripheral nerve.
- 12. High abuse potential, no approved medical use - heroin, marijuana, LSD, etc.
- 14. process of safely administering anesthetic agents to induce unconsciousness before surgery or medical procedures.
- 15. Examples: Penicillin, Amoxicillin.
- 16. Undesirable and potentially harmful effect of a medication.
- 19. Used to control bleeding.Examples: Thrombin, Gelatin sponges.
- 20. Anesthesia to the distal portion of the upper extremity.
- 21. Administering anesthetic along major nerve tracts.
- 24. Lower abuse potential than Schedule III, approved medical use - benzodiazepines like Valium, Ativan, etc.
- 25. Less abuse potential than Schedule II, approved medical use - hydrocodone, codeine combinations, etc.
- 27. Potential risks associated with general anesthesia, including but not limited to airway compromise, cardiovascular depression, and allergic reactions.
- 28. Metric system, household system, and apothecary system.
- 30. Physical or psychological need for the effect of a medication.
- 31. Applies a nerve-blocking agent to the skin or mucous membrane.
- 33. Aspiration, potentially leading to lung infections if protective measures aren't taken.
- 35. Enteral (oral, rectal), parenteral (intradermal, subcutaneous, intramuscular, intravenous), and topical.
- 37. (1)Used as a topical hemostatic agent.(2)Derived from bovine origin.
- 38. High abuse potential, approved medical use with severe restrictions - morphine, oxycodone, etc.
- 39. Unacceptable effect of a medication.
- 43. Effects of the medication at the target site.